Clinical Trials

Showing trials with last updates posted in 2016.

NCT02979561 | UNKNOWN | PHASE4
200 participants

Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2016-12-20
Start Date:
2016-10-31
Completion:
2018-06-30
Conditions
  • Angiographically Confirmed Acute Massive Pulmonary Embolism Treated With Endovascular Mechanical Fragmentation and Thrombolytic Therapy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page